Videos and Podcasts

Has the pandemic exacerbated alcohol harm?

Men have always been at greater risk of harm than women from alcohol use, but the pandemic may have exacerbated the problem. What can we do? Sir Ian Gilmore (Professor of Hepatology) shares his thoughts on the issue.

How can bowel cancer outcomes be improved?

Humphrey Scott (Consultant Surgeon and Dean of the Royal Society of Medicine) discusses developments in screening and management of colorectal cancer – a disease that is more common in men and increasing in younger patients.

Morbidity associated with osteoporosis significant in older men

Older men are at greater risk of mortality in hospital from fracture and have more osteoporosis-associated complications. Ali Jawad (Professor of Rheumatology) discusses the management options.

Avoiding litigation in the age of telemedicine

Telemedicine is increasingly important for non-emergency healthcare provision. Chaitya Desai (Core Surgical Trainee with Masters in Law) takes a look at the legal implications and discusses best practice for clinicians.

Understanding military-related mental illness for effective health care

The experiences of military personnel have a particular impact on their mental health and influence whether they seek help. Walter Busuttil (Consultant Psychiatrist and Director for Research and Training at Combat Stress) will help you understand and address their needs.

The gut microbiome, health and personalised nutrition

The human gut microbiome modulates health and disease and can be manipulated by lifestyle and diet. Federica Amati (Nutritionist and Research Associate) considers what we know to date and what the future might hold for this rapidly evolving field of science and technology, including its role in personalised health.

How do gut microbes influence mental health?

Ted Dinan (Professor of Psychiatry) considers the impact of gut microbes on brain function and mental state, and reflects on the role of diet in managing depression.

The need for a strategy on men’s health

Alan White (Professor Emeritus of Men’s Health) discusses the need for a national strategy on men’s health that recognises it as a whole life-course issue, and how you can support it.

Haematospermia: when are investigation and treatment appropriate

Haematospermia is often benign, but can be a source of anxiety and over-investigation. Maria Satchi (Consultant Urological Surgeon and Andrologist) describes appropriate investigation of the condition and treatment options.

Haematuria: what is the real cancer risk? Results from the IDENTIFY study

Sinan Khadhouri (Urology Registrar and BURST Co-chair) discusses the results and implications of he IDENTIFY study – the largest prospective international cohort study conducted among patients referred with haematuria to secondary care.

Testosterone deficiency, the unrecognised consequence of the opioid epidemic in men

Testosterone deficiency resulting from chronic opioid use often goes unrecognised and untreated. Janine David (GP and Associate Specialist in Andrology) and Mike Kirby (Editor of Trends in Urology and Men’s Health) review the problem and discuss strategies for management.

Fulminating COVID-19 infection: my personal experience

Geoff Hackett (Consultant Urologist) takes us on a very personal journey through his experience of a severe COVID-19 infection, hospitalisation and subsequent recovery, along with the sequelae. His experience and subsequent research have left him convinced of the value of phosphodiesterase type-5 inhibitors and testosterone in the treatment of men hospitalised with COVID-19.

Results from the PROSTAGRAM study

In this interview, Dr Hannah Warren speaks with David Eldred-Evans and Ben Challacombe on the important results of the recent PROSTAGRAM study, which demonstrated the benefits of MRI scanning compared to traditional PSA testing in screening for prostate cancer.

Testosterone, COVID-19 and tadalafil

In this new video Professor Mike Kirby, Editor of Trends in Urology and Men’s Health, and Professor Geoff Hackett, Consultant in Sexual Medicine at Birmingham NHS Foundation Trust, discuss the results of recent research published on the association between testosterone and COVID-19.

Peyronie’s disease: how to take images of penile curvature

In penile conditions, examination is crucial to diagnosis, management, and patient counselling. Previously, these examinations have been carried out in-person, but the current COVID-19 pandemic has meant that remote consultations have become the norm – so that obtaining accurate digital images is crucial for diagnosis...

COVID-19: biological factors in men’s vulnerability

The current COVID-19 outbreak has raised many questions, in particular the disproportionately higher number of deaths among men compared with women. Due to the severity of the pandemic, a vast (and often confusing) amount of information has rapidly been published on the subject – yet our...

Journal watch: recent medical studies with a ‘take-home message’

In the next in our series of Trends in Urology and Men’s Health podcasts, Mike Kirby, Editor of Trends in Urology and Men’s Health, returns to the microphone to go over some important recent medical studies along with his own ‘take-home message’...

Testicular cancer, testosterone deficiency and the metabolic syndrome

In the first of a series of Trends in Urology and Men’s Health podcasts, Mike Kirby, GP and Visiting Professor to the University of Hertfordshire, discusses the association between testicular cancer surgery and the subsequent development of testosterone deficiency and the metabolic syndrome...

Management of urinary incontinence following prostate cancer treatment

In this short video Culley Carson, Rhodes Distinguished Professor and Chief of Urology at the University of North Carolina, USA, discusses the current outcomes of prostate cancer treatment; in particular, the management of urinary incontinence using a male sling or artificial urinary sphincter...

Peyronie’s disease: a less known issue of erectile dysfunction

In this short video Culley Carson, Rhodes Distinguished Professor and Chief of Urology at the University of North Carolina, USA, discusses the diagnosis and management of Peyronie’s disease. In particular, he asks clinicians to remain aware of it as a potential diagnosis in patients presenting...

Erectile dysfunction after radical treatment for prostate cancer

A survey commissioned by Prostate Cancer UK highlighted that, when asked, many men feel they get limited advice or support on sexual dysfunction as a consequence of radical treatment for prostate cancer. In particular, the survey made clear that patients undergoing radiotherapy often get little advice...

My prostate cancer diagnosis

In this short video, Stephen Fry candidly discusses how an elevated PSA level during his annual health check set off a chain of further medical tests that resulted in his eventual diagnosis with prostate cancer. After hearing the fateful words ‘I’m a little worried about your PSA...

Cardiovascular outcome trials in diabetes

Professor Mike Kirby, GP and Visiting Professor to the University of Hertfordshire and The Prostate Centre, London, discusses diabetes in men and what we have learnt from the recent cardiovascular outcome trials on diabetes drugs...